SAHA SAURABH - Insider Non-Derivative Transactions at Centessa Pharmaceuticals plc (CNTA) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on Jul 21, 2025, SAHA SAURABH's relationship to Centessa Pharmaceuticals plc (CNTA) is Director,Officer (Chief Executive Officer), and currently has 276,017 shares of Ordinary Shares.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CNTA insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
SAHA SAURABH - Insider Non-Derivative Transactions of CNTA Ordinary Shares
SAHA SAURABH - Insider Non-Derivative Transactions at CNTA
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 22, 2025 | Sell -- (Ordinary Shares) | 55000 | 15.92 | 221017 |
| Jul 22, 2025 | M -- (Ordinary Shares) | 55000 | 3.85 | 276017 |
| Jun 21, 2025 | Sell -- (Ordinary Shares) | 55000 | 12.63 | 221017 |
| Jun 21, 2025 | M -- (Ordinary Shares) | 55000 | 3.85 | 276017 |
| May 21, 2025 | Sell -- (Ordinary Shares) | 55000 | 12.71 | 221017 |
| May 21, 2025 | M -- (Ordinary Shares) | 55000 | 3.85 | 276017 |
| Apr 23, 2025 | Sell -- (Ordinary Shares) | 40344 | 12.43 | 221017 |
| Apr 22, 2025 | Sell -- (Ordinary Shares) | 14656 | 12.29 | 261361 |
| Mar 21, 2025 | Sell -- (Ordinary Shares) | 55000 | 16.69 | 276017 |
| Feb 21, 2025 | Sell -- (Ordinary Shares) | 775 | 16.54 | 331017 |
| Feb 21, 2025 | Sell -- (Ordinary Shares) | 54225 | 15.92 | 331792 |
| Feb 2, 2025 | F -- (Ordinary Shares) | 43381 | 16.92 | 386017 |
| Jan 22, 2025 | Sell -- (Ordinary Shares) | 1625 | 16.19 | 429398 |
| Jan 22, 2025 | Sell -- (Ordinary Shares) | 53375 | 15.76 | 431023 |
| Jan 1, 2025 | F -- (Ordinary Shares) | 36263 | 16.35 | 484398 |
| Dec 21, 2024 | Sell -- (Ordinary Shares) | 55000 | 17.44 | 520661 |
| Dec 7, 2024 | Sell -- (Ordinary Shares) | 87496 | 18.46 | 575661 |
| Dec 7, 2024 | M -- (Ordinary Shares) | 87496 | 5.84 | 663157 |
| Nov 26, 2024 | Sell -- (Ordinary Shares) | 299 | 18.23 | 575661 |
| Nov 26, 2024 | M -- (Ordinary Shares) | 299 | 5.84 | 575960 |
| Nov 23, 2024 | Sell -- (Ordinary Shares) | 1671 | 18.24 | 575661 |
| Nov 23, 2024 | M -- (Ordinary Shares) | 1671 | 5.84 | 577332 |
| Nov 22, 2024 | Sell -- (Ordinary Shares) | 3511 | 18.24 | 575661 |
| Nov 22, 2024 | M -- (Ordinary Shares) | 3511 | 5.84 | 579172 |
| Nov 21, 2024 | Sell -- (Ordinary Shares) | 55000 | 16.89 | 575661 |
| Nov 14, 2024 | Sell -- (Ordinary Shares) | 32023 | 18.28 | 630661 |
| Nov 14, 2024 | M -- (Ordinary Shares) | 32023 | 5.84 | 662684 |
| Oct 24, 2024 | Sell -- (Ordinary Shares) | 2592 | 15.32 | 630661 |
| Oct 23, 2024 | Sell -- (Ordinary Shares) | 30203 | 15.67 | 633253 |
| Oct 22, 2024 | Sell -- (Ordinary Shares) | 22205 | 15.8 | 663456 |
| Oct 1, 2024 | F -- (Ordinary Shares) | 36263 | 15.79 | 685661 |
| Sep 21, 2024 | Sell -- (Ordinary Shares) | 55000 | 16.53 | 721924 |
| Sep 11, 2024 | Sell -- (Ordinary Shares) | 175000 | 16.52 | 776924 |
| Sep 11, 2024 | M -- (Ordinary Shares) | 175000 | 5.84 | 951924 |
| Aug 24, 2024 | Sell -- (Ordinary Shares) | 46651 | 12.3 | 776924 |
| Aug 23, 2024 | Sell -- (Ordinary Shares) | 506 | 12.23 | 823575 |
| Aug 22, 2024 | Sell -- (Ordinary Shares) | 3674 | 12.25 | 824081 |
| Aug 21, 2024 | Sell -- (Ordinary Shares) | 4169 | 12.32 | 827755 |
| Jul 1, 2024 | F -- (Ordinary Shares) | 36263 | 9.03 | 831924 |
| Apr 1, 2024 | F -- (Ordinary Shares) | 36263 | 11.3 | 868187 |
| Feb 2, 2024 | F -- (Ordinary Shares) | 26323 | 8.19 | 904450 |
| Feb 2, 2024 | Acquisition -- (Ordinary Shares) | 144200 | 0 | 930773 |
| Jan 1, 2024 | F -- (Ordinary Shares) | 36263 | 7.96 | 786573 |
| Oct 1, 2023 | F -- (Ordinary Shares) | 36263 | 6.47 | 822836 |
| Jul 1, 2023 | F -- (Ordinary Shares) | 36263 | 5.9 | 859099 |
| Apr 1, 2023 | F -- (Ordinary Shares) | 22013 | 3.9 | 895362 |
| Feb 2, 2023 | Acquisition -- (Ordinary Shares) | 211400 | 0 | 917375 |
| Jan 1, 2023 | F -- (Ordinary Shares) | 44025 | 3.1 | 705975 |